Market Closed -
Nasdaq
04:00:00 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
41.43
USD
|
+3.42%
|
|
+3.65%
|
+8.17%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
642.4
|
672.2
|
3,279
|
1,348
|
1,706
|
2,026
|
-
|
-
|
Enterprise Value (EV)
1 |
642.4
|
672.2
|
3,279
|
1,258
|
1,691
|
1,948
|
1,853
|
2,026
|
P/E ratio
|
47.2
x
|
18.1
x
|
45.1
x
|
27.4
x
|
29.7
x
|
27
x
|
23
x
|
15.4
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
0.3%
|
0.38%
|
-
|
Capitalization / Revenue
|
1.15
x
|
0.98
x
|
4.24
x
|
1.18
x
|
1.23
x
|
1.15
x
|
0.94
x
|
0.75
x
|
EV / Revenue
|
1.15
x
|
0.98
x
|
4.24
x
|
1.1
x
|
1.22
x
|
1.11
x
|
0.86
x
|
0.75
x
|
EV / EBITDA
|
8.62
x
|
5.31
x
|
18.9
x
|
8.99
x
|
11.5
x
|
11.1
x
|
9
x
|
8.26
x
|
EV / FCF
|
-
|
-
|
-
|
21.3
x
|
42.6
x
|
26.6
x
|
18.2
x
|
-
|
FCF Yield
|
-
|
-
|
-
|
4.7%
|
2.35%
|
3.76%
|
5.5%
|
-
|
Price to Book
|
-
|
-
|
-
|
2.49
x
|
2.92
x
|
2.89
x
|
2.63
x
|
-
|
Nbr of stocks (in thousands)
|
34,893
|
36,790
|
44,623
|
45,548
|
44,548
|
48,893
|
-
|
-
|
Reference price
2 |
18.41
|
18.27
|
73.48
|
29.59
|
38.30
|
41.43
|
41.43
|
41.43
|
Announcement Date
|
3/12/20
|
3/10/21
|
2/24/22
|
2/23/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
560.6
|
687.2
|
773.9
|
1,144
|
1,387
|
1,761
|
2,158
|
2,707
|
EBITDA
1 |
74.5
|
126.5
|
173.1
|
140
|
146.6
|
175.3
|
205.8
|
245.1
|
EBIT
1 |
34.41
|
80.5
|
98.18
|
104.3
|
84.61
|
124
|
146.9
|
190.2
|
Operating Margin
|
6.14%
|
11.71%
|
12.69%
|
9.11%
|
6.1%
|
7.04%
|
6.81%
|
7.03%
|
Earnings before Tax (EBT)
1 |
25.84
|
178.4
|
77.75
|
86.62
|
89.84
|
122.1
|
146.6
|
195.4
|
Net income
1 |
14.12
|
37.87
|
73.86
|
49.05
|
60.72
|
78.8
|
94.23
|
149.9
|
Net margin
|
2.52%
|
5.51%
|
9.54%
|
4.29%
|
4.38%
|
4.47%
|
4.37%
|
5.54%
|
EPS
2 |
0.3900
|
1.010
|
1.630
|
1.080
|
1.290
|
1.533
|
1.800
|
2.690
|
Free Cash Flow
1 |
-
|
-
|
-
|
59.19
|
39.7
|
73.18
|
101.8
|
-
|
FCF margin
|
-
|
-
|
-
|
5.17%
|
2.86%
|
4.16%
|
4.72%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
42.27%
|
27.08%
|
41.73%
|
49.48%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
120.67%
|
65.38%
|
92.86%
|
108.08%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
0.1249
|
0.1560
|
-
|
Announcement Date
|
3/12/20
|
3/10/21
|
2/24/22
|
2/23/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
195.1
|
-
|
-
|
317
|
294.2
|
337.2
|
348.2
|
348.2
|
353
|
404.4
|
440.4
|
452.1
|
462.6
|
492.4
|
518.5
|
EBITDA
1 |
38.74
|
-
|
-
|
57.14
|
23.65
|
29.82
|
35.77
|
51.97
|
29.01
|
42.24
|
45.71
|
51.56
|
37.98
|
48.96
|
51.45
|
EBIT
1 |
2.248
|
-
|
-
|
50.09
|
12.58
|
22.37
|
27.03
|
39.08
|
-3.87
|
30.14
|
32.72
|
35.56
|
25.11
|
-
|
-
|
Operating Margin
|
1.15%
|
-
|
-
|
15.8%
|
4.28%
|
6.63%
|
7.76%
|
11.23%
|
-1.1%
|
7.45%
|
7.43%
|
7.87%
|
5.43%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-22.43
|
-
|
-
|
41.26
|
10.46
|
19.41
|
31.49
|
38.02
|
0.924
|
24
|
36.48
|
40.39
|
25.08
|
-
|
-
|
Net income
1 |
13.77
|
-
|
-
|
25.99
|
-2.6
|
14.62
|
13.17
|
22.06
|
12.36
|
14.84
|
21.18
|
25.27
|
21.02
|
-
|
-
|
Net margin
|
7.06%
|
-
|
-
|
8.2%
|
-0.88%
|
4.34%
|
3.78%
|
6.34%
|
3.5%
|
3.67%
|
4.81%
|
5.59%
|
4.54%
|
-
|
-
|
EPS
2 |
0.3000
|
0.3100
|
0.2500
|
0.5600
|
-0.0600
|
0.3100
|
0.2800
|
0.4700
|
0.2600
|
0.3100
|
0.4200
|
0.4817
|
0.3167
|
0.4100
|
0.4400
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/24/22
|
5/5/22
|
8/4/22
|
11/3/22
|
2/23/23
|
5/8/23
|
8/7/23
|
11/7/23
|
2/27/24
|
5/7/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
89.6
|
15.4
|
77.7
|
173
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
59.2
|
39.7
|
73.2
|
102
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
10.5%
|
19.2%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
-
|
11.90
|
13.10
|
14.40
|
15.70
|
-
|
Cash Flow per Share
2 |
-
|
-
|
-
|
1.800
|
1.450
|
0.8600
|
2.290
|
-
|
Capex
1 |
-
|
-
|
-
|
22.9
|
28.5
|
21.8
|
13.5
|
21.8
|
Capex / Sales
|
-
|
-
|
-
|
2%
|
2.06%
|
1.24%
|
0.63%
|
0.8%
|
Announcement Date
|
3/12/20
|
3/10/21
|
2/24/22
|
2/23/23
|
2/27/24
|
-
|
-
|
-
|
Last Close Price
41.43
USD Average target price
54.17
USD Spread / Average Target +30.74% Consensus |
1st Jan change
|
Capi.
|
---|
| +8.17% | 2.03B | | +25.52% | 88.99B | | -24.52% | 74.82B | | -5.56% | 25.03B | | +4.31% | 17.88B | | -14.25% | 16.43B | | +2.97% | 15.77B | | +79.20% | 13.21B | | +70.11% | 13.08B | | +40.44% | 12.9B |
Other Healthcare Facilities & Services
|